Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
Allist Pharmaceuticals, Inc.
Allist Pharmaceuticals, Inc.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Rutgers, The State University of New Jersey
Klus Pharma Inc.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Shanghai Hengrui Pharmaceutical Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
First Affiliated Hospital of Zhejiang University
BeBetter Med Inc
Evopoint Biosciences Inc.
Universitair Ziekenhuis Brussel
Tang-Du Hospital
Shanghai Yizhong Pharmaceutical Co., Ltd.
Celgene
Sun Yat-sen University
Shanghai University of Traditional Chinese Medicine
Shanghai Gebaide Biotechnology Co., Ltd.
Betta Pharmaceuticals Co., Ltd.
Spectrum Pharmaceuticals, Inc
Telik